Wellgistics Health, Inc. announced key unaudited operational performance highlights for the first quarter of 2025 on April 30, 2025. The company reported adding 354 new independent pharmacies to its nationwide network during the quarter. This expansion signals continued acceleration across its national platform.
The company also onboarded 22 new pharmaceutical manufacturers in Q1 2025. Additionally, 57 new prescription drug products were integrated into its portfolio. These numbers demonstrate a clear demand for the company's solutions within the industry.
CEO Brian Norton stated that these figures indicate the industry is demanding change. This operational growth supports Wellgistics Health's strategy to build a micro health ecosystem. The company aims to provide integrated technology and pharmaceutical services.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.